Provided by Tiger Trade Technology Pte. Ltd.

Rocket Pharmaceuticals, Inc.

3.27
-0.1600-4.66%
Volume:2.08M
Turnover:7.03M
Market Cap:353.89M
PE:-1.46
High:3.57
Open:3.45
Low:3.26
Close:3.43
52wk High:13.35
52wk Low:2.19
Shares:108.22M
Float Shares:78.79M
Volume Ratio:0.66
T/O Rate:2.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2397
EPS(LYR):-2.7292
ROE:-74.88%
ROA:-40.56%
PB:1.13
PE(LYR):-1.20

Loading ...

Rocket Pharmaceuticals announces new equity compensation package for Chief Medical Officer

Reuters
·
Oct 11

Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Oct 11

Rocket Pharmaceuticals Files Initial Beneficial Ownership Statement for Director Peter Fong

Reuters
·
Oct 04

Leerink Partners Adjusts Rocket Pharmaceuticals Price Target to $7 From $9, Maintains Market Perform Rating

MT Newswires Live
·
Oct 04

Rocket Pharmaceuticals Is Maintained at Market Perform by Leerink Partners

Dow Jones
·
Oct 03

BUZZ-U.S. STOCKS ON THE MOVE-Occidental Petroleum , GameStop, Alphabet

Reuters
·
Oct 03

Rocket Pharmaceuticals price target lowered to $7 from $9 at Leerink

TIPRANKS
·
Oct 03

Rocket Pharmaceuticals withdraws BLA for Fanskya

TIPRANKS
·
Oct 03

Rocket Pharmaceuticals withdraws US application of gene therapy for rare blood disorder

Reuters
·
Oct 03

Rocket Pharmaceuticals Inc - Withdraws Bla for Mozafancogene Autotemcel - SEC Filing

THOMSON REUTERS
·
Oct 03

Rocket Pharmaceuticals Appoints Dr. Peter Fong to Board Following Dr. Gotham Makker’s Resignation

Reuters
·
Sep 30

Rocket Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for Syed Ali-aamir Rizvi, Chief Medical Officer

Reuters
·
Sep 24

Cantor Fitzgerald Sticks to Their Buy Rating for Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
Sep 23

BofA Upgrades Rocket Pharmaceuticals to Buy From Neutral, Adjusts Price Target to $24 From $21

MT Newswires Live
·
Sep 10

BUZZ-U.S. STOCKS ON THE MOVE- Gap, Aquestive Therapeutics, Lumentum

Reuters
·
Sep 04

BUZZ-US FDA program favorable for rare disease drug developers, says Jefferies

Reuters
·
Sep 04

Rocket Pharmaceuticals Inc. to Participate in Cantor Fitzgerald Global Healthcare Conference

Reuters
·
Aug 28

Director Elisabeth Bjork Reports Acquisition of Common Shares in Rocket Pharmaceuticals Inc

Reuters
·
Aug 28

Rocket Pharmaceuticals Inc - CFO Aaron Ondrey Resigns Effective September 5, 2025 - SEC Filing

THOMSON REUTERS
·
Aug 26

Rocket Pharmaceuticals Inc - Martin Wilson Appointed Interim Principal Financial Officer of Rocket Pharmaceuticals - SEC Filing

THOMSON REUTERS
·
Aug 26